Ian Ford

4 ta ish

University of Glasgow

1. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

   Bryan Williams, Thomas M. MacDonald, S. V. Morant +10

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.211224

2. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

   James Shepherd, Stuart M. Cobbe, Ian Ford +5

   MaqolaOAOchiq kirish19952 iqtibos

   ABIABI:AkademIndex/2026.other.057686

3. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

   Steven H J Hageman, Lisa Pennells, Francisco Ojeda +97

   MaqolaOAOchiq kirish20212 iqtibos

   ABIABI:AkademIndex/2026.other.057801

4. Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial

   Thomas M. MacDonald, Bryan Williams, David J. Webb +12

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.295839